Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8235 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8225 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8225 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8136 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8111 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD37 |
Approved |
0.8037 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8034 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7966 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7944 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7944 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7921 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.791 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7801 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.779 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7735 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.768 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6776 |
Approved |
0.764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7611 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7592 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD7874 |
Approved |
0.756 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7526 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7513 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7462 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7437 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7418 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7398 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7398 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7382 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7362 |
Intermediate Similarity |
NPD3764 |
Approved |
0.736 |
Intermediate Similarity |
NPD7999 |
Approved |
0.736 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7327 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7326 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7326 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7294 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7258 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7235 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7207 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.72 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7198 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7176 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6764 |
Approved |
0.716 |
Intermediate Similarity |
NPD6099 |
Approved |
0.716 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7159 |
Intermediate Similarity |
NPD3226 |
Approved |
0.715 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7101 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7024 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3748 |
Approved |
0.6994 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7095 |
Approved |
0.6982 |
Remote Similarity |
NPD1607 |
Approved |
0.6971 |
Remote Similarity |
NPD1511 |
Approved |
0.6967 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD1240 |
Approved |
0.6959 |
Remote Similarity |
NPD2438 |
Suspended |
0.6959 |
Remote Similarity |
NPD2796 |
Approved |
0.6948 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD6798 |
Discontinued |
0.694 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5710 |
Approved |
0.6919 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5711 |
Approved |
0.6919 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6919 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6901 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6897 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD1512 |
Approved |
0.6893 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD9545 |
Approved |
0.6871 |
Remote Similarity |
NPD3972 |
Approved |
0.6871 |
Remote Similarity |
NPD1608 |
Approved |
0.6869 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD8485 |
Approved |
0.6867 |
Remote Similarity |
NPD5736 |
Approved |
0.6864 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6864 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD4140 |
Approved |
0.6862 |
Remote Similarity |
NPD7177 |
Discontinued |
0.686 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6847
|
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |